BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15208305)

  • 21. The G(2) checkpoint is maintained by redundant pathways.
    Passalaris TM; Benanti JA; Gewin L; Kiyono T; Galloway DA
    Mol Cell Biol; 1999 Sep; 19(9):5872-81. PubMed ID: 10454534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
    Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
    J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
    Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
    Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway.
    de Ruiter ND; Wolthuis RM; van Dam H; Burgering BM; Bos JL
    Mol Cell Biol; 2000 Nov; 20(22):8480-8. PubMed ID: 11046144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells.
    Winters ZE; Ongkeko WM; Harris AL; Norbury CJ
    Oncogene; 1998 Aug; 17(6):673-84. PubMed ID: 9715268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of G2 arrest in response to overexpression of p53.
    Taylor WR; DePrimo SE; Agarwal A; Agarwal ML; Schönthal AH; Katula KS; Stark GR
    Mol Biol Cell; 1999 Nov; 10(11):3607-22. PubMed ID: 10564259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
    Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
    Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
    Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
    Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase.
    Chow JP; Siu WY; Fung TK; Chan WM; Lau A; Arooz T; Ng CP; Yamashita K; Poon RY
    Mol Biol Cell; 2003 Oct; 14(10):3989-4002. PubMed ID: 14517313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.
    Senga T; Iwamoto T; Kitamura T; Miyake Y; Hamaguchi M
    J Biol Chem; 2001 Aug; 276(35):32678-81. PubMed ID: 11432872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
    Chow JP; Siu WY; Ho HT; Ma KH; Ho CC; Poon RY
    J Biol Chem; 2003 Oct; 278(42):40815-28. PubMed ID: 12912980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadmium-induced DNA damage triggers G(2)/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells.
    Bork U; Lee WK; Kuchler A; Dittmar T; Thévenod F
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F255-65. PubMed ID: 19923412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
    Bunz F; Dutriaux A; Lengauer C; Waldman T; Zhou S; Brown JP; Sedivy JM; Kinzler KW; Vogelstein B
    Science; 1998 Nov; 282(5393):1497-501. PubMed ID: 9822382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminus of p53 is required for G(2) arrest.
    Nakamura S; Gomyo Y; Roth JA; Mukhopadhyay T
    Oncogene; 2002 Mar; 21(13):2102-7. PubMed ID: 11960383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.